Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Parvovirus-like particles in human sera.

Y E Cossart, A M Field, B Cant

    Lancet (London, England)
    |January 11, 1975
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Impact of media brand on cefiderocol disk diffusion results.

    Journal of clinical microbiology·2025
    Same author

    Predicting high-throughput screening results with scalable literature-based discovery methods.

    CPT: pharmacometrics & systems pharmacology·2014
    Same author

    Fractional pixel translations of Fresnel lenses written onto spatial light modulators.

    Applied optics·2010
    Same author

    Subharmonic focal-length intensities formed by Fresnel lenses.

    Applied optics·2010
    Same author

    Evaluation of acid phosphatase as a confirmation test for Clostridium perfringens isolated from water.

    Letters in applied microbiology·2006
    Same author

    The current pattern of hepatitis B virus infection in Australia.

    Journal of viral hepatitis·2006

    A novel parvovirus-like antigen was detected in blood donors and patients. While its health effects remain unknown, many adults have antibodies, and it resembles hepatitis-B antigen.

    Area of Science:

    • Virology
    • Immunology
    • Hepatology

    Background:

    • A parvovirus-like antigen has been identified in human sera.
    • Its clinical significance and pathogenicity are currently undetermined.
    • Distinguishing this agent from hepatitis B virus is crucial due to morphological and serological similarities.

    Purpose of the Study:

    • To report the detection of a novel parvovirus-like antigen in human blood.
    • To investigate the seroprevalence of specific antibodies against this agent in the adult population.
    • To highlight potential diagnostic challenges related to its similarity with hepatitis B antigen.

    Main Methods:

    • Detection of the parvovirus-like antigen in serum samples from healthy blood donors and patients.
    • Serological assays to determine the prevalence of specific antibodies in adults.

    Related Experiment Videos

  • Comparative morphological and serological analysis against known viral antigens, including hepatitis B antigen.

    • Main Results:

    • The parvovirus-like antigen was identified in sera from nine healthy blood donors and two patients.
    • A significant proportion of the adult population (30%) possesses specific antibodies against this agent.
    • Morphological and serological tests indicated a potential for confusion with hepatitis B antigen.

    Conclusions:

    • A parvovirus-like agent circulates in the human population, with evidence of exposure in a substantial portion of adults.
    • Further research is required to elucidate the pathogenicity and clinical implications of this newly identified antigen.
    • Awareness of its resemblance to hepatitis B antigen is essential for accurate laboratory diagnosis and patient management.